Mode
Text Size
Log in / Sign up
Phase 4 Completed N=65 Randomized Quadruple-blind Treatment

Bupropion for Smoking Cessation During Pregnancy

Pregnancy Related · Tobacco Use
Source: ClinicalTrials.gov NCT01390246 ↗
Enrolled (actual)
65
Serious AEs
10.8%
Results posted
Feb 2018
Primary outcomePrimary: Change in Cigarette Craving and Total Nicotine Withdrawal Symptoms Between Groups During Medication Treatment — 1.50; 2.07; 3.77; 5.35 MNWS Score
◆ Published Evidence
Established
33citations · ~4 / year
Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial.
American journal of obstetrics and gynecology · 2017 · Open access · High-confidence link

Summary

This is a prospective, double-blind placebo-controlled randomized pilot trial of the preliminary safety and efficacy of bupropion SR in combination with behavioral counseling for smoking cessation during pregnancy.

Linked Publications

  • Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial.
    American journal of obstetrics and gynecology · 2017 · 33 citations · Open access · High-confidence link

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Cigarette Craving and Total Nicotine Withdrawal Symptoms Between Groups During Medication Treatment
1.50; 2.07; 3.77; 5.35
PRIMARY
Change in Cigarette Craving and Total Nicotine Withdrawal Symptoms Between Groups on the Quit Date
2.04; 2.33; 4.75; 4.88
PRIMARY
Number of Participants With 7-day Point Prevalence Smoking Abstinence at the End of Medication Treatment (Visit 6)
5; 1
PRIMARY
Number of Participants With 7-day Point Prevalence Smoking Abstinence at the End of Pregnancy (Visit 7)
3; 1

Eligibility Criteria

Inclusion Criteria

  • smoking at least 10 CPD prior to pregnancy and 5 CPD for the preceding 7 days
  • 13-30 weeks gestation
  • ≥18 years of age
  • able to speak English or Spanish
  • intent to carry pregnancy to term
  • stable residence

Exclusion Criteria

  • current illicit drug or alcohol abuse or dependence
  • twins or other multiple gestation
  • treatment for psychiatric disorder within the last 6 months
  • unstable medical problems (eg, hypertension (BP>140/90), preeclampsia, threatened abortion, hyperemesis gravidarum)
  • known congenital abnormality
  • seizure disorder
  • use of psychotropic medication
  • use of medication known to lower the seizure threshold
  • anorexia/bulimia
  • a personal history of closed head trauma with > 30 minutes of loss of consciousness or amnesia or resulting in skull fracture or subdural hematoma/brain contusion
  • use of any other smoking cessation treatment in the past 30 days
  • current enrollment in methadone treatment program
  • prior pregnancy with preeclampsia diagnosis
  • chronic hypertension (past history or current diagnosis)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01390246) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search